Gadour Eyad
Department of Gastroenterology and Hepatology, King Abdulaziz National Guard Hospital, Ahsa 36428, Saudi Arabia.
Internal Medicine, Zamzam University College, Khartoum 11113, Sudan.
World J Transplant. 2025 Mar 18;15(1):93253. doi: 10.5500/wjt.v15.i1.93253.
Over the past six decades, liver transplantation (LT) has evolved from an experimental procedure into a standardized and life-saving intervention, reshaping the landscape of organ transplantation. Driven by pioneering breakthroughs, technological advancements, and a deepened understanding of immunology, LT has seen remarkable progress. Some of the most notable breakthroughs in the field include advances in immunosuppression, a revised model for end-stage liver disease, and artificial intelligence (AI)-integrated imaging modalities serving diagnostic and therapeutic roles in LT, paired with ever-evolving technological advances. Additionally, the refinement of transplantation procedures, resulting in the introduction of alternative transplantation methods, such as living donor LT, split LT, and the use of marginal grafts, has addressed the challenge of organ shortage. Moreover, precision medicine, guiding personalized immunosuppressive strategies, has significantly improved patient and graft survival rates while addressing emergent issues, such as short-term complications and early allograft dysfunction, leading to a more refined strategy and enhanced post-operative recovery. Looking ahead, ongoing research explores regenerative medicine, diagnostic tools, and AI to optimize organ allocation and post-transplantation car. In summary, the past six decades have marked a transformative journey in LT with a commitment to advancing science, medicine, and patient-centered care, offering hope and extending life to individuals worldwide.
在过去的六十年里,肝移植(LT)已从一种实验性手术发展成为一种标准化的、挽救生命的干预措施,重塑了器官移植的格局。在开创性突破、技术进步以及对免疫学的深入理解的推动下,肝移植取得了显著进展。该领域一些最显著的突破包括免疫抑制方面的进展、终末期肝病修订模型以及在肝移植中发挥诊断和治疗作用的人工智能(AI)集成成像模式,同时伴随着不断发展的技术进步。此外,移植手术的完善,带来了如活体供体肝移植、劈离式肝移植以及使用边缘供肝等替代移植方法的引入,解决了器官短缺的挑战。此外,精准医学指导个性化免疫抑制策略,在解决诸如短期并发症和早期移植肝功能障碍等紧急问题的同时,显著提高了患者和移植肝的存活率,从而形成了更精细的策略并促进了术后恢复。展望未来,正在进行的研究探索再生医学、诊断工具和人工智能,以优化器官分配和移植后护理。总之,过去六十年标志着肝移植领域的变革之旅,致力于推动科学、医学以及以患者为中心的护理,为全球各地的人们带来希望并延长生命。